Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

US Patent 10954268 · Granted Mar 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions2025
Pharmaceutical compositions2025
Method of treating melanocortin-4 receptor pathway-associated disorders2025
Method of treating melanocortin-4 receptor pathway-associated disorders2025
Peptide compositions2024
Peptide compositions2024
Compositions and methods for treating mitochondrial neurogastrointestinal enceph2024
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and meth2024
Method of treating melanocortin-4 receptor-associated disorders in heterozygous 2023
Method of treating melanocortin-4 receptor-associated disorders in heterozygous 2023
Method of treating melanocortin-4 receptor-associated disorders in heterozygous 2023
Method of treating osteoporosis comprising administration of PTHrP analog2023